UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation

Digestive diseases and sciences, 2017-02, Vol.62 (2), p.481-490

2017

Volltextzugriff (PDF)

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

Clinical gastroenterology and hepatology, 2020-01, Vol.18 (1), p.89-98

2020

Volltextzugriff (PDF)

Redes sociales online y enfermedad inflamatoria intestinal

Revista española de enfermedades digestivas, 2018, Vol.110 (5), p.271-273

2018

Volltextzugriff (PDF)

Online social networks and inflammatory bowel disease

Revista española de enfermedades digestivas, 2018-05, Vol.110 (5), p.271

2018

Volltextzugriff (PDF)

EUS-guided drainage of postsurgical pelvic abscesses using lumen-apposing metal stents

Revista española de enfermedades digestivas, 2019-07, Vol.111 (7), p.566-568

2019

Volltextzugriff (PDF)

Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)

Helicobacter (Cambridge, Mass.), 2020-10, Vol.25 (5), p.e12722-n/a

2020

Volltextzugriff (PDF)

Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab

Revista española de enfermedades digestivas, 2017-02, Vol.109 (2), p.122-129

2017

Volltextzugriff (PDF)

Accuracy of GastroPanel for the diagnosis of atrophic gastritis

European journal of gastroenterology & hepatology, 2014-09, Vol.26 (9), p.941-948

2014

Volltextzugriff (PDF)

Online social networks and inflammatory bowel disease

Revista española de enfermedades digestivas, 2018-05, Vol.110 (5), p.271-273

2018

Volltextzugriff (PDF)

Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients

Inflammatory bowel diseases, 2015-07, Vol.21 (7), p.1631-1640

2015

Volltextzugriff (PDF)

Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva

Revista española de enfermedades digestivas, 2016-04, Vol.108 (4), p.207-224

2016

Volltextzugriff (PDF)

Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)

Journal of clinical gastroenterology, 2022-02, Vol.56 (2), p.e98-e108

2022

Volltextzugriff (PDF)

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice

Gut, 2014-02, Vol.63 (2), p.244-249

2014

Volltextzugriff (PDF)

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

Gut, 2010-10, Vol.59 (10), p.1340-1346

2010

Volltextzugriff (PDF)

Limited effectiveness with a 10‐day bismuth‐containing quadruple therapy (Pylera®) in third‐line recue treatment for Helicobacter pylori infection. A real‐life multicenter study

Helicobacter (Cambridge, Mass.), 2017-10, Vol.22 (5), p.n/a

2017

Volltextzugriff (PDF)

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain

Antibiotics (Basel), 2021-01, Vol.10 (1), p.13

2021

Volltextzugriff (PDF)

Tu1107 Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-789-S-789

2015

Volltextzugriff (PDF)

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)

Journal of Crohn's and colitis, 2014-11, Vol.8 (11), p.1529-1538

2014

Volltextzugriff (PDF)

Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-326-S-327

2013

Volltextzugriff (PDF)

Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis)

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-393-S-393

2014

Volltextzugriff (PDF)

Su1705 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice. Interim Results

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-485-S-485

2012

Volltextzugriff (PDF)

S1035 The Risk of Severe Crohn's Disease: Validation of a Clinical Prediction Rule

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-174-A-174

2009

Volltextzugriff (PDF)

Rituximab-associated colitis

Gastroenterología y hepatología, 2019-04, Vol.42 (4), p.251

2019

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Gastroenterology & Hepatology
(16)
Humans
(15)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Adult
(12)
Female
(11)
Male
(11)
Middle Aged
(9)
Gastroenterology And Hepatology
(7)
Prospective Studies
(7)
Helicobacter Pylori
(6)
Infectious Diseases
(6)
Young Adult
(6)
Antibiotics
(5)
Treatment Outcome
(5)
Adalimumab
(4)
Aged
(4)
Bismuth
(4)
Clarithromycin
(4)
Helicobacter Infections - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

Redes sociales online y enfermedad inflamatoria intestinal

Online social networks and inflammatory bowel disease

EUS-guided drainage of postsurgical pelvic abscesses using lumen-apposing metal stents

Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)

Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab

Accuracy of GastroPanel for the diagnosis of atrophic gastritis

Online social networks and inflammatory bowel disease

Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients

Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva

The Risk of Developing Disabling Crohn’s Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making

Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

Limited effectiveness with a 10‐day bismuth‐containing quadruple therapy (Pylera®) in third‐line recue treatment for Helicobacter pylori infection. A real‐life multicenter study

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain

Tu1107 Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis

Tu1335 European Registry on H. pylori Management (HP-EuReg) in Spain: Interim Analysis in First and Second Line Therapies

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)

Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice

Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis)

Su1705 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice. Interim Results

S1035 The Risk of Severe Crohn's Disease: Validation of a Clinical Prediction Rule

Rituximab-associated colitis

Suchergebnisse filtern